I thought this was an interesting proposition, that MS meds may have greater effect, in larger groups, than clinical trial data indicates.
The suggestion is that MS damage takes longer to play out, so the full beneficial effects may not be fully evident in the limited time of clinical trials. Think Ocrevus for PPMS.
Only registered and activated users can see links., Click Here To Register...
The suggestion is that MS damage takes longer to play out, so the full beneficial effects may not be fully evident in the limited time of clinical trials. Think Ocrevus for PPMS.
Only registered and activated users can see links., Click Here To Register...

Please Note that my posts may have been arbitrarily altered by a Moderator and may not reflect my original content.
Comment